Obesity-associated genetic variants in young Asian Indians with the metabolic syndrome and myocardial infarction

Cardiovascular Journal of Africa

Volumn 22, Issue 1, 2011, Pages 25-30

  Ranjith, Naresh ^a   Pegoraro, Rosemary J ^a   Shanmugam, Rebecca ^a  

^a NONE

Author keywords

Genetic polymorphisms; Metabolic syndrome; Myocardial infarction; Obesity

Indexed keywords

ACID LIPASE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MELANOCORTIN 4 RECEPTOR; FAT MASS AND OBESITY ASSOCIATED PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN RECEPTOR; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; GENE FREQUENCY; INDIAN; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 79951619361     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-036     Document Type: Article

References (41)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidema, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
2. Lindsay RS, Howard BV. Cardiovascular risk associated with the metabolic syndrome. Curr Diab Rep 2004; 4: 63-68. (Pubitemid 39359512)
3. Koh KK, Han SH, Quon MJ. Inflammatory markers and the metabolic syndrome insights from therapeutic interventions. J Am Coll Cardiol 2005; 46: 1978-1985. (Pubitemid 41713578)
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3134-3421.
5. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome, April 14, 2005. Acessed at http://www.idf.org/ webdata/docs/Metac-syndrome-def.pdf/ on June 10, 2005.
6. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163(4): 427-436.
7. Palaniappan L, Carnethon MR, Wang Y, et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004; 27: 788-793. (Pubitemid 38280551)
8. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002; 51: 2325-2328. (Pubitemid 34729044)
9. Menzaghi C, Ercolino T, Di Paola R, et al. A haplotype in the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002; 51: 2306-2312. (Pubitemid 34729040)
10. Filippi E, Sentinelli F, Trischitta V, et al. Association of the human adiponectin gene and insulin resistance. Eur J Hum Genet 2004; 12: 199-205. (Pubitemid 38499978)
11. Hu FB, Doria A, Li T, et al. Genetic variation at the adiponectin locus and risk of type 2 diabetes in women. Diabetes 2004; 53: 209-213. (Pubitemid 38044717)
12. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981. (Pubitemid 39540124)
13. Yatagai T, Nagasaka S, Tamiguchi A, Fukushima M, Nakamura T, Kuroe A, et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274-1278. (Pubitemid 37351094)
14. Yamamoto Y, Hirose H, Saito I, et al. Adiponectin, an adipocyte-derived protein, predicts future insulin-resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004; 89: 87-90. (Pubitemid 38183864)
15. Han SH, Quon MJ, Kim JA, et al. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007; 49: 531-538. (Pubitemid 46177440)
16. Sattar N, Wannamethee G, Sarwar N, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114: 623-629. (Pubitemid 44252303)
17. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metab 2001; 86: 4321-4325. (Pubitemid 32848553)
18. Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999; 130: 871-881.
19. Echwald SM, Sorensen TD, Sorensen TI, et al. Amino acid variants in the human leptin receptor: lack of association to juvenile onset obesity. Biochem Biophys Res Commun 1997; 233: 248-252. (Pubitemid 27215945)
20. Gotoda T, Manning BS, Goldstone AP, et al. Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet 1997; 6: 869-876. (Pubitemid 27239070)
21. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S. Clinical specturm of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 2003; 348: 1085-1095. (Pubitemid 36337319)
22. Biebermann H, Castaneda TR, van Landeghem F, von Deimiling A, Escher F, Brabant G, et al. A role for beta-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab 2006; 3: 141-146.
23. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. E-publication 26th June 2009. PLoS Genet 2009; 3: e115.
24. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007; 316: 889-894. (Pubitemid 46764279)
25. Ranjith N, Pegoraro RJ, Naidoo DP, et al. Metabolic syndrome in young Asian Indian patients with myocardial infarction. Cardiovasc J S Afr 2007; 18: 21-26.
26. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
27. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation on Obesity, Geneva, 3-5 June, 1997. Geneva, Switzerland: World Health Organization, 1998. (WHO TRS 894).
28. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings form the third National Health and Nutrition Examination Survey. J Am Med Assoc 2002; 287: 356-359. (Pubitemid 34251969)
29. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U. S. Adults. Diabetes Care 2004; 27: 2444-2449. (Pubitemid 39281399)
30. Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation 2007; 115: 2111-2118. (Pubitemid 46659062)
31. Bajaj M, Banerji MA. Type 2 diabetes in South Asians: a pathophysiologic focus on the Asian-Indian epidemic. Curr Diab Rep 2004; 4: 213-218. (Pubitemid 38899151)
32. Tanaka S, Horimai C, Katsukawa F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta Diabetol 2003; 40(Suppl 1) S302-S304. (Pubitemid 37322782)
33. Baguleyan CG. Hospital data on coronary artery disease from North Kerala. In: Vijayaraghavan G, ed. Cardiovascular Disease Prevention. Trivandrum, India: Trivandrum Medical College, 1996: 54-59.
34. Filippi E. Sentinelli F, Romeo S, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤ 50 years). J Mol Med 2005; 83: 711-179.
35. Jung CH, Rhee EJ, Kim SY, et al. Associations between two single nucleotide polymorphisms of adiponectin gene and coronary artery diseases. Endocrine J 2006; 5: 671-677.
36. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51: 536-540. (Pubitemid 34764814)
37. Yiannakouris N, Yannakoulia M, Melistas L, et al. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocr Metab 2001; 86: 4434-4439. (Pubitemid 32848571)
38. Mergen H, Karaaslan C, Mergen M, et al. LEPR, ADBR3 IRS-1 and 5-HTT gene polymorphisms do not associate with obesity. Endocr J 2007; 54: 89-94. (Pubitemid 46481676)
39. Cauchi S, Stutzmann F, Cavalcanti-Proenca C, et al. Combined effects of MC4R and FTO common genetic variants on obesity in European general populations. J Mol Med 2009; 87: 537-546.
40. Bacci S, Menzaghi C, Ercolino T, et al. The +276G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 2004; 27: 2015-2020. (Pubitemid 38989248)
41. Qi L, Li T, Rimm E, et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 2005; 54: 1607-1610. (Pubitemid 40586698)